STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — Cara Therapeutics Inc. (CARA) on Monday reported a loss of $32.3 million in its fourth quarter.

On a per-share basis, the Stamford, Connecticut-based company said it had a loss of 59 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share.

The biotechnology company posted revenue of $3 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $2.3 million.

For the year, the company reported that its loss widened to $118.5 million, or $2.19 per share. Revenue was reported as $21 million.

In the final minutes of trading on Monday, the company's shares hit $1. A year ago, they were trading at $9.80.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News